Happy New Year! Following onto the strong life science presence at the January chapter forums (all but one of the presentations were life science), we have a very full agenda for our first life science committee screening for 2018. Three companies will be presenting on Monday, Jan. 29th:
- Seattle Gummy (Connie Wan, CEO)
- Tasso (Ben Casavant, CEO)
- Majelco Medical (Annette MacIntyre, President)
The first two companies are planning to present in person at the Keiretsu offices conference room, and the last company (Majelco) will present via GoToMeeting web conference. I have attached the executive summary and investor slide deck for each company for your preview to prepare for this meeting.
Given the packed agenda, please be prompt at joining the meeting at 4:00. Since we have three companies this month, the meeting will last until 6:00. Please remember to only enable one microphone if there are more than one device accessing the meeting in the room (otherwise there will be feedback), and to mute your microphone when not speaking so that background noises do not disturb the web conference.
For those members that will be participating via web conference, the GoToMeeting access is:
Life Science Committee Screening
Please join my meeting from your computer, tablet or smartphone.
You can also dial in using your phone.
United States: +1 (646) 749-3112
Access Code: 499-691-861
First GoToMeeting? Let's do a quick system check: https://link.gotomeeting.com/system-check
2017-08 Tasso Short Pitch Deck v11.pdf
Majelco Slide Deck v11.1.pdf
2018Q1 Tasso Executive Summary.pdf
Executive Summary Jan 2018.pdf
Life Science Committee Meeting Jan 29 2018.pdf
To post to this group, send email to firstname.lastname@example.org or visithttps://keiretsuforum-northwest.proseeder.com/life-science-healthcare-committee-keiretsu-forum-pacific-northwest.
Keiretsu Forum Pacific Northwest does not make any recommendations about investments. Each member of Keiretsu Forum Pacific Northwest must recognize that she/he must make her/his own decision about any investment made, and must not rely upon the staff or management of Keiretsu Forum Pacific Northwest, nor upon any member of Keiretsu Forum Pacific Northwest.